Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRMalaysia Clinical Laboratory Services Market, By Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services), Specialty (Clinical Chemistry Testing, Haematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing and Genetic Testing), Provider (Hospital-Based Laboratories, Independent and Reference Laboratories, Clinical-Based Laboratories, and Nursing and Physician Office-Based Laboratories), Application (Bioanalytical and Lab Chemistry Services, Drug Development Related Services, Drug Discovery Related Services, Toxicology Testing Services, Cell, and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services, and Other Clinical Laboratory Services), Country (Malaysia) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Malaysia Clinical Laboratory Services Market
Malaysia clinical laboratory services market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the Malaysia clinical laboratory services market is growing with a CAGR of 5.8% in the forecast period of 2021 to 2028 and is expected to reach USD 3,130.48 million by 2028 from USD 2,006.35 million in 2020. Growing adoption for digital pathology platforms and advancement in clinical diagnostic methods are the major drivers that propelled the market's demand in the forecast period.
Clinical laboratories are an important part of the healthcare sector. Most diagnostic tests, starting from the blood test to the genetic analysis, are conducted in these clinical laboratories to detect diseases. Clinical laboratories offer data and resources that optimize the required distribution in the healthcare system, such as diagnostics and test results. This maintains and provides reliable and correct test results that enable doctors to make appropriate clinical and diagnostic decisions across various levels of health care services.
The increasing adoption of digital pathology has further propelled the demand for clinical laboratory services. The high prevalence of infectious diseases across Malaysia and the increasing awareness of early and accurate diagnosis is likely to fuel the growth of the clinical laboratory services market. Moreover, inadequate reimbursement policies act as a challenge for the market. The strategic initiatives by market players and rising preventive health check-ups act as an opportunity for the market's growth. However, inaccurate test results and stringent regulatory policies act as a restraint for its growth in the market.
Malaysia clinical laboratory services market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Malaysia Clinical Laboratory Services Market Scope and Market Size
Malaysia clinical laboratory services market is segmented based on service type, specialty, provider, and application. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of service type, the Malaysia clinical laboratory services market is segmented into routine testing services, esoteric services, and anatomic pathology services. In 2021, the routine testing services segment is expected to dominate the market due to the rising awareness of early and accurate diagnosis.
- On the basis of specialty, the Malaysia clinical laboratory services market is segmented into clinical chemistry testing, microbiology testing, haematology testing, genetic testing, drugs of abuse testing, and immunology testing. In 2021, the clinical chemistry testing segment is expected to dominate the market due to the rise in advanced clinical diagnostic methods for accurate test results.
- On the basis of provider, the Malaysia clinical laboratory services market is segmented into independent and reference laboratories, hospital-based laboratories, and nursing and physician office-based laboratories. In 2021, the hospital-based laboratories segment is expected to dominate the market due to an increase in infectious disease cases, which leads to high patient volumes and high test demand.
- On the basis of application, the Malaysia clinical laboratory services market is segmented into drug discovery related services, drug development related services, bioanalytical and lab chemistry services, toxicology testing services, cell and gene therapy related services, preclinical and clinical trial related services, and other clinical laboratory services. In 2021, the bioanalytical and lab chemistry services segment is expected to dominate due to new variants of infectious diseases.
Rising Preference of Preventive Health Check-Ups and Increasing Strategic Initiatives by Market Players in the Market is Creating New Opportunities for Players in the Malaysia Clinical Laboratory Services Market
Malaysia clinical laboratory services market also provides you with a detailed market analysis of market sales, impact of advancement in the Malaysia clinical laboratory services market, and changes in regulatory scenarios with their support for the Malaysia clinical laboratory services market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Malaysia Clinical Laboratory Services Market Share Analysis
The Malaysia clinical laboratory services market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company’s focus on the Malaysia clinical laboratory services market.
The major players covered in the Malaysia clinical laboratory services market report are Eurofins Scientific, Siemens Healthcare GmbH, Abbott, DaVita Inc., Charles River Laboratories, Laboratory Corporation of America Holdings, Sunway Med Lab, PT Kimia Farma Diagnostika, SGS SA, and Syneos Health, among others and domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies that accelerate the Malaysia clinical laboratory services market.
For instances,
- In June, Eurofins Scientific announced that its subsidiary Eurofins Clinical Testing US Holdings, Inc. entered into an agreement for acquisition Diagnostics Center (“DDC”) which is aa leader in consumer genetic testing services. This Acquisition has benefitted the company in terms of expanding its testing services in consumer genetic testing.
- In February, Siemens Healthcare GmbH offered lab-based antigen test for high-throughput analyzers and expands COVID-19 test capacities. Company obtained CE Mark for its laboratory-based SARS-CoV-2 Antigen Assay (CoV2Ag); the test will be offered at the Atellica Solution and ADVIA Centaur®analyzers, widely available in laboratories worldwide.
SKU-
